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Bcc are opportunistic pathogen bacteria with a signiﬁcant impact over CF. Trans-
missibility of Bcc among these patients is well studied. However, no sufﬁcient data
on Bcc transmission between CF and non CF individuals are available.
We studied two episodes of Bcc isolates from non CF children hospitalized in the
same area with CF patients. In the ﬁrst one, strains of Bcc were isolated from two
immunocompromised patients at the Infectious Diseases Unit (IDU), where a CF
child with chronic Bcc infection was hospitalized. The second episode happened
in the ICU in a non CF patient assisted near a CF child with intermittent Bcc
colonization. Strains from all non CF children were isolated from blood culture.
Isolates were identiﬁed through biochemical tests and recA PCR. Species of Bcc
strains were determined through recA gene sequence analysis. Air and surface
samples of each room were also obtained.
Both IDU immunocompromised patients had B. cenocepacia B, while the CF child
was infected with B. contaminans. In one IDU air sample a B. contaminans was
found. In the ICU, the CF child had been colonized with B. cepacia while the non
CF patient cultured a B. contaminans.
Analysis of the species isolated in both cases could not demonstrate any evidence
of cross infection between CF and non CF patients. Although strict infection
control measures are required in CF Bcc positive patients, detection of Bcc in
other non CF patients may have other sources of infection such as environmental
or contaminated medical material.
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Infections with Burkholderia species (B.spp) and Stenotrophomonas maltophilia
(St.malt) are relatively rare among patients with CF. Looking at large populations
may be beneﬁcial.
Methods: We analysed data from the year 2007 on 15,057 CF patients from 15
countries in the European CF Registry. Using a common deﬁnition, data on chronic
infection with B.spp was reported from 9039 patients in 9 countries and for St.malt
from 7634 patients in 7 countries. Prevalence was standardized by age. Odds ratios
(OR) for FEV-1 40% and BMI z-score −2 were adjusted for age, gender and
country.
Results: Overall prevalence of chronic B.spp infection was 2.54%, with age
standardized prevalence from 1.03 (95% CI: 0.83–1.27) to 6.59% (CI: 6.07–7.14)
across countries. Patients with B.spp infection had twice (95% CI: 1.41; 2.84) the
odds of FEV1 40% than patients without infection and 1.32 (CI: 0.78; 2.23) the
odds of having a BMI z-score −2. For St.malt the overall prevalence was 3.76%
and age-standardized prevalence varied from 0.79 (CI: 0.60–1.01) to 9.91% (CI:
9.21–10.64). Adjusted OR for FEV-1 40% was 1.56 (1.09; 2.24) and for BMI
z-score −2 1.18 (0.76; 1.87).
Conclusion: The prevalence of chronic infection of both these gram negative
infections is low, but varies between countries, even when adjusting for the different
age structure of the CF populations. B.spp infection is associated with low FEV1,
but not low BMI. The association between St.malt and low FEV1 is signiﬁcant,
but much weaker and there is no association to low BMI. Infection prevention and
aggressive treatment of B.spp is recommended. Further monitoring of infection with
St.malt in more countries is warranted.
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Burkholderia cepacia complex bacteria (Bcc) are considered serious pathogens that
cause respiratory infections in patients with cystic ﬁbrosis (CF), although anecdotal
evidence indicates that asymptomatic colonization and clearance of infection may
occur. Bcc have the capacity to spread, due to which patient segregation is in place
in many CF centres. To improve the infection control, it is advisable to diagnose
Bcc infection as early as possible. We therefore exploited a previously published
PCR method that allowed detecting low quantities of Bcc in sputum. By analyzing
longitudinal microbiology data we assessed contribution of the PCR method to early
Bcc diagnostics and also identiﬁed patients who cleared the infection and became
Bcc free.
From 2001 to end of 2009, at least 2 Bcc positive samples were found in 107/424
CF patients examined: 86 cases were diagnosed simultaneously by both PCR and
culture, but in 21 patients the ﬁrst positivity was detectable only by PCR. This
positivity never converted into culture positivity in 10/21 patients, while 11/21
patients became eventually culture positive 1 to 63 months following the ﬁrst PCR
detection of Bcc. Interestingly, 17/107 patients turned into Bcc negativity (3 neg.
consecutive samples) after being colonized for 1 to 45 months. In 6 out of these
17 patients, we never succeeded to culture Bcc.
The data highlights usefulness of PCR in Bcc detection as delay/failure of culture-
based diagnostics was apparent in 20% (21/107) of Bcc positive patients. “Silent”
Bcc colonization disappeared in 16% (17/107) of cases out of which ca. 1/3 was
diagnosed only by PCR.
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Introduction: B. cenocepacia and B. multivorans has been described as the most
important BCC genomovars for lung function deterioration in CF patients. The
aim of this study was to assess the prevalence and genomovar distribution of BCC
among CF patients seen at the outpatient pediatric CF reference center.
Methods: In the last 4 years 2768 samples from respiratory tract of 217 CF patients
were obtained (3 cultures/patient/year). The samples were grown in non-selective
and selective medium, including the BCSA and phenotypically identiﬁed by bio-
chemical tests and the Vitek®II. Subsequently the genomic DNA was extracted
and BCC was identiﬁed by PCR recA gene ampliﬁcation, using BCR1 and BCR2
primers. A second ampliﬁcation was carried out by nested-PCR method, with BCC
genomovars speciﬁc primers.
Results and Discussion: BCC prevalence was 20.7% (45/217), 31.1% (14/45)
were transient colonization, chronic 26.7% (12/45), 8.9% intermittent (4/45), 26.7%
of new cases (12/45) and 6.6% (3/45) were excluded due to patient follow-up
loss. Although other studies published in Brazil and other American and European
countries have found prevalence of genomovar III − Burkholderia cenocepacia,
in this study the genomovar II − B. multivorans was the most prevalent (26.7%),
followed by genomovar I − B. cepacia (24.5%) and genomovar III − B. cenocepacia
(8.9%). We could not identify the genomovar from 13 patients and failed to
recover the agent for 12 patients. Among patients with chronic colonization was
observed the presence of more than one genomovar in 13.3% (6/45). The BCSA
selective medium used after 2006 allowed to detect early colonization in 26.7% of
patients (12/45).
